MediQuest is a specialty pharmaceutical company developing first- and best- in-class topical therapies to treat patients suffering from inflammatory and infectious diseases. Using a proprietary drug delivery technology, MediQuest can deliver a topical therapy through thickened or diseased skin and nails. The Company's innovative treatment approach and proprietary drug delivery system have generated a robust late-stage clinical pipeline aimed at treating inflammatory/infectious diseases and satisfying unmet medical needs.